Cystic fibrosis

461,802views

Cystic fibrosis

Gastrointestinal

Gastrointestinal

Esophagitis: Clinical sciences
Esophageal disorders: Pathology review
Esophageal cancer: Clinical sciences
Esophageal cancer
Esophageal perforation: Clinical sciences
Esophageal cancer: Year of the Zebra
Eosinophilic esophagitis (NORD)
Esophageal disorders: Clinical
Gastroesophageal reflux disease: Clinical sciences
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Approach to melena and hematemesis: Clinical sciences
Esophagitis: Clinical
Achalasia: Year of the Zebra
Gastroesophageal reflux disease (GERD)
Esophageal web
Barrett esophagus
Diffuse esophageal spasm
Portal hypertension
Mallory-Weiss syndrome: Clinical sciences
Gastrointestinal bleeding: Pathology review
Gastroesophageal varices: Clinical sciences
Cirrhosis: Clinical sciences
Gastroesophageal reflux disease (GERD): Clinical
Gastric cancer: Clinical sciences
Peptic ulcer disease: Clinical sciences
Pancreatic cancer
Pancreatitis: Pathology review
Chronic pancreatitis
Acute pancreatitis
Pancreatic neuroendocrine neoplasms
Chronic pancreatitis: Clinical sciences
Pancreatic cancer: Clinical sciences
Acute pancreatitis: Clinical sciences
Zollinger-Ellison syndrome
Multiple endocrine neoplasia: Clinical sciences
Cystic fibrosis
Stress ulcers: Clinical sciences
Ulcerative colitis
Inflammatory bowel disease (ulcerative colitis): Clinical sciences
Inflammatory bowel disease: Pathology review
Gallbladder carcinoma
Gallbladder disorders: Pathology review
Acute cholecystitis
Gallstones
Gallstone ileus
Cholecystitis: Clinical sciences
Biliary colic
Chronic cholecystitis
Approach to upper abdominal pain: Clinical sciences
Choledocholithiasis and cholangitis: Clinical sciences
Ascending cholangitis
Cholestatic liver disease
Jaundice: Pathology review
Jaundice
Approach to jaundice (unconjugated hyperbilirubinemia): Clinical sciences
Approach to jaundice (conjugated hyperbilirubinemia): Clinical sciences
Jaundice: Clinical
Neonatal jaundice: Clinical
Hepatitis A and Hepatitis E virus
Hepatitis B and Hepatitis D virus
Viral hepatitis
Hepatitis C virus
Viral hepatitis: Pathology review
Hepatitis C: Clinical sciences
Hepatitis B: Clinical sciences
Hepatitis A and E: Clinical sciences
Alcohol-induced hepatitis: Clinical sciences
Hepatic encephalopathy
Viral hepatitis: Clinical
Hepatocellular carcinoma
Cirrhosis: Pathology review
Colorectal cancer
Ischemic colitis: Clinical sciences
Colorectal polyps
Colorectal polyps and cancer: Pathology review
Colorectal cancer: Clinical sciences
Approach to constipation: Clinical sciences
Approach to hematochezia: Clinical sciences
Diverticulitis: Clinical sciences
Large bowel obstruction: Clinical sciences
Fecal impaction: Clinical sciences
Diverticular disease: Pathology review
Small bowel obstruction: Clinical sciences
Clostridium difficile (Pseudomembranous colitis)
Inflammatory bowel disease (Crohn disease): Clinical sciences
Diverticulosis and diverticulitis
Ileus: Clinical sciences
Familial adenomatous polyposis

Transcript

Watch video only

You’re probably aware that cystic fibrosis, or CF, is a genetic disorder that affects the lungs, but that’s only part of the story.

In fact, the name “cystic fibrosis,” refers to the disease’s effects on the pancreas, where it can lead to cysts, which are fluid-filled sacs wrapped in a membrane and fibrosis—excess deposition of connective tissue that can replace or infiltrate normal tissue in an organ.

CF is an autosomal recessive disorder involving the CFTR gene, which stands for “cystic fibrosis transmembrane conductance regulator,” and this gene codes for the CFTR protein.

CF develops when there’s a mutation in the CFTR gene, but because it’s autosomal recessive, you need to inherit two mutated CFTR genes, one from mom and one from dad.

Now if mom and dad both have one copy of the mutated gene and one normal gene, they’re considered carriers and don’t have the disease.

Inheriting CF is more common in people of European descent.

The CFTR protein is a channel protein that pumps chloride ions into various secretions, those chloride ions help draw water into the secretions, which ends up thinning them out.

The most common mutation is the “∆F508” mutation.

Delta means a deletion, and the F (which can also be written as “Phe”) is short for phenylalanine, and the 508 is the five hundred and 8th amino acid in the CFTR protein.

So, the ∆F508 mutation is where the 508th amino acid out of 1480, phenylalanine, is deleted and missing.

This CFTR protein with the ∆F508 mutation gets misfolded and can’t migrate from the endoplasmic reticulum to the cell membrane, meaning there’s a lack of CFTR protein on the epithelial surface, and this means that it can’t pump chloride ions out, which means water doesn’t get drawn in, and the secretions are left overly thick.

In a newborn, thick secretions can affect the baby’s meconium, or first stool, or, which can get so thick and sticky that it might get stuck in the baby’s intestines and not come out, and this is called a meconium ileus and is a surgical emergency.

In early childhood, pancreatic insufficiency is the most prominent effect of CF.

This happens because thick secretions jam up the pancreatic ducts, not allowing digestive enzymes to make it to the small intestine.

Without those pancreatic enzymes, protein and fat aren’t absorbed.

And over time this can lead to poor weight gain and failure to thrive.

Fat malabsorption can lead to steatorrhea, or fat-containing stools.

Eventually the pancreas gets damaged, because backed-up digestive enzymes degrade the cells lining the pancreatic ducts, causing local inflammation.

This can lead to acute pancreatitis and—with repeated episodes—chronic pancreatitis, with the development of cysts and fibrosis like we talked about, giving the disease it’s name.

Finally, the destruction of pancreatic tissue can also compromise of the endocrine function of the pancreas, causing insulin-dependent diabetes.

It’s usually not until later in childhood that lung problems start to crop up.

Normally the cilia, these hair-like projections lining the airways, do a pretty good job of keep the them clean by moving mucus, which catches things like debris and bacteria, toward the pharynx, called mucociliary action.

With thick mucus, though, it gets a lot harder to clear and the mucociliary action becomes defective, which means bacteria is allowed to chronically colonize the lungs.

If the bacterial load suddenly increases, it causes symptoms like cough and fever, a decrease in lung function, and sometimes changes on a chest X-ray, and this is called a CF exacerbation and usually prompts a round of antibiotics.

Pneumonia is one example of a CF exacerbation which requires antibiotic treatment.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "Cystic Fibrosis: Lessons from the Sweat Gland" Physiology (2007)
  6. "Infection Control in Cystic Fibrosis" Clinical Microbiology Reviews (2004)
  7. "Pharmacological approaches for targeting cystic fibrosis nonsense mutations" European Journal of Medicinal Chemistry (2020)